Viridian Therapeutics

+$0.29 (+2.44%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRDN and other ETFs, options, and stocks.

About VRDN

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis.

CEO
Jonathan Violin
Employees
50
Headquarters
Waltham, Massachusetts
Founded
2006

VRDN Key Statistics

Market cap
340.44M
Price-Earnings ratio
—
Dividend yield
—
Average volume
210.66K
High today
$12.47
Low today
$11.56
Open price
$11.91
Volume
168.47K
52 Week high
$22.00
52 Week low
$9.47

VRDN Earnings

-$5.31
-$3.54
-$1.77
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure